These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32168319)

  • 21. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
    Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
    J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
    Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
    Chan WKB; Zhang Y
    J Mol Biol; 2020 Aug; 432(17):4872-4890. PubMed ID: 32652079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.
    Vilar S; Ferino G; Phatak SS; Berk B; Cavasotto CN; Costanzi S
    J Mol Graph Model; 2011 Feb; 29(5):614-23. PubMed ID: 21146435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the Modeling of Extracellular Ligand Binding Pockets in RosettaGPCR for Conformational Selection.
    Liessmann F; Künze G; Meiler J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
    Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
    Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.
    Nguyen ED; Norn C; Frimurer TM; Meiler J
    PLoS One; 2013; 8(7):e67302. PubMed ID: 23844000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology model-assisted elucidation of binding sites in GPCRs.
    Levit A; Barak D; Behrens M; Meyerhof W; Niv MY
    Methods Mol Biol; 2012; 914():179-205. PubMed ID: 22976029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
    Vass M; Kooistra AJ; Verhoeven S; Gloriam D; de Esch IJP; de Graaf C
    Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for improved modeling of GPCR-drug complexes: blind predictions of serotonin receptors bound to ergotamine.
    Rodríguez D; Ranganathan A; Carlsson J
    J Chem Inf Model; 2014 Jul; 54(7):2004-21. PubMed ID: 25030302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
    Daga PR; Polgar WE; Zaveri NT
    J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability of AlphaFold2 Models in Virtual Drug Screening: A Focus on Selected Class A GPCRs.
    Alhumaid NK; Tawfik EA
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PREDICT modeling and in-silico screening for G-protein coupled receptors.
    Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
    Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang H; Wang XS; Hsieh JH; Tropsha A
    Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
    Yarnitzky T; Levit A; Niv MY
    Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the performance of MM/PBSA for binding affinity prediction using class A GPCR crystal structures.
    Yau MQ; Emtage AL; Chan NJY; Doughty SW; Loo JSE
    J Comput Aided Mol Des; 2019 May; 33(5):487-496. PubMed ID: 30989574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Receptor-ligand docking simulation for membrane proteins].
    Hirokawa T
    Yakugaku Zasshi; 2007 Jan; 127(1):123-31. PubMed ID: 17202792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.